JPRN-UMIN000004611已完成4 期
Efficacy and safety of change the antiplatelet agent in patients with chronic noncardioembolic ischemic stroke - multi-center prospective study - - Efficacy and safety of change the antiplatelet agent in patients with chronic noncardioembolic ischemic stroke
eurosurgery,Kawasaki Medical School0 个研究点目标入组 120 人开始时间: 2010年12月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with cardioembolic ischemic stroke. 2. Patients with hemorrhage or bleeding tendency. 3. Patients with congestive heart failure. 4. Patients with a history of hypersensitivity to ingredients of cilostazol. 5. Pregnant, possibly pregnant, or nursing women. 6. Patients on cilostazol 7. Patients with CAS for asymptomatic stroke. 8. Patients during the argatroban, ozagrel sodium or scheduled. 9. Patients during the rt-PA or scheduled. 10. Patients with scheduled on neuroendovascular therapy. 11. Patients on experimental drug or scheduled. 12. Patients who are otherwise judged inappropriate for inclusion in the study by the investigators.
研究者
相似试验
尚未招募
不适用
A clinical trial to study effects of clopidogrel and newer antiplatelet agents ( Ticagrelor and Prasugrel) in patients with acute coronary syndrome who underwent PCI.CTRI/2021/12/038560N Mehta institute of cardiology and research center
招募中
4 期
A randomized clinical trial of an antiplatelet agent in the treatment of acute stroke: cilostazol in the prevention of acute progressing stroke (CAPS) studyCerebral infarctionJPRN-UMIN000001630Tohoku Acute Progressing Stroke Study Group500
招募中
不适用
Effect and safety of tailored antiplatelet therapy based on platelet function testing in coil embolization for unruptured aneurysmKCT0005550Bundang Jesaeng Hospital1,780
终止
不适用
Efficacy of antiplatelet therapy in reducing risk of recurrence for patients with hepatocellular carcinomaNeoplasmsKCT0004846Seoul National University Hospital288
已完成
4 期
The efficacy and safety of the antiplatelet therapy in acute non-cardiogenic ischemic stroke.on-cardiogenic ischemic stroke in acute phase.JPRN-UMIN000006931Department of Neurosurgery, Faculty of Medicine, University of Tsukuba130